After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that U.S. Food and Drug Administration (FDA) Accepts Supplemental New Drug Application for KRAZATI® (adagrasib) in Combination with Cetuximab as a Targeted Treatment Option for Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or..
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NYSE and operates within the Drug Manufacturers – General industry segment. The current market capitalization of Bristol-Myers Squibb Co. is $102.95B. A total of 11.99 million shares were traded on the day, compared to an average of 15.51M shares.
Insider Activity
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, BMY has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 85 BUYs and 51 SELLs from insiders. Insiders purchased 708,048 shares during that period but sold 423,399.
In the most recent transaction, BOERNER CHRISTOPHER S. bought 2,000 shares of BMY for 49.78 per share on Dec 05. After the transaction, the Chief Executive Officer now owns 82,672 company shares. In a previous transaction on Nov 28, BOERNER CHRISTOPHER S. bought 3,071 shares at 48.86 per share. BMY shares that Chief Executive Officer owns now total 79,384.
Among the insiders who bought shares, Samuels Theodore R. II acquired of 8,500 shares on Nov 20 at a per-share price of $49.81. This resulted in the Director holding 35,500 shares of BMY after the transaction. In another insider transaction, Powell Ann sold 17,986 shares at $61.25 per share on Aug 24. Company shares held by the EVP, Chief Human Resources now total 27,868.
Dividend
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Bristol-Myers Squibb Co. pays an annual dividend of $2.31, resulting in a dividend yield of 4.54%, and it has a price to earnings (P/E) ratio of 13.20. BMY’s most recent ex-dividend date was 1/4/2024 when it declared a $0.60 quarterly dividend that was paid in cash on 2/1/2024. Previously, the company paid the dividend on 11/1/2023 with an ex-dividend date of 10/5/2023. The BMY stock dividend was $0.57 per share in cash.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for BMY in the last 3 months, the mean price target is $55.42 with high estimates of $68.00 and low estimates of $41.00. In terms of 52-week highs and lows, BMY has a high of $71.98 and a low of $47.58.
As of this writing, BMY has an earnings estimate of $1.57 per share for the current quarter. EPS was calculated based on a consensus of 15 estimates, with a high estimate of $1.94 per share and a lower estimate of $1.3. The company reported an EPS of $1.82 in the last quarter, which was 13.00% higher than expectations of $1.61.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BMY’s latest balance sheet shows that the firm has $17.22B in Cash & Short Term Investments as of fiscal 2021. There were $45.60B in debt and $21.87B in liabilities at the time. Its Book Value Per Share was $14.56, while its Total Shareholder’s Equity was $36.01B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BMY is Buy with a score of 3.29.
